ArticleGut2025

Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease.

Jimmy Che-To Lai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.